XML 20 R6.htm IDEA: XBRL DOCUMENT v3.25.0.1
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Series A  preferred stock
Series A  preferred stock
Common stock
Additional paid-in capital
Accumulated other comprehensive income (loss)
Accumulated deficit
Beginning balance (in shares) at Mar. 31, 2023   10,000 130,329,863      
Beginning balance at Mar. 31, 2023 $ 362,494 $ 0 $ 13 $ 927,976 $ 852 $ (566,347)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock options exercised and restricted stock units vested and settled (in shares)     235,566      
Stock options exercised and restricted stock units vested and settled 890     890    
Capital contribution – stock-based compensation 35     35    
Stock-based compensation 10,653     10,653    
Foreign currency translation adjustments (270)       (270)  
Net loss (73,937)         (73,937)
Ending balance (in shares) at Jun. 30, 2023   10,000 130,565,429      
Ending balance at Jun. 30, 2023 299,865 $ 0 $ 13 939,554 582 (640,284)
Beginning balance (in shares) at Mar. 31, 2023   10,000 130,329,863      
Beginning balance at Mar. 31, 2023 362,494 $ 0 $ 13 927,976 852 (566,347)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (184,017)          
Ending balance (in shares) at Dec. 31, 2023   10,000 145,094,052      
Ending balance at Dec. 31, 2023 679,344 $ 0 $ 14 1,430,294 (600) (750,364)
Beginning balance (in shares) at Jun. 30, 2023   10,000 130,565,429      
Beginning balance at Jun. 30, 2023 299,865 $ 0 $ 13 939,554 582 (640,284)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock options exercised and restricted stock units vested and settled (in shares)     876,595      
Stock options exercised and restricted stock units vested and settled 148     148    
Capital contribution – stock-based compensation 28     28    
Stock-based compensation 10,501     10,501    
Foreign currency translation adjustments (69)       (69)  
Net loss (58,662)         (58,662)
Ending balance (in shares) at Sep. 30, 2023   10,000 131,442,024      
Ending balance at Sep. 30, 2023 251,811 $ 0 $ 13 950,231 513 (698,946)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock upon underwritten public offering and private placement (in shares)     12,949,184      
Issuance of common stock upon underwritten public offering and private placement 466,733   $ 1 466,732    
Stock options exercised and restricted stock units vested and settled (in shares)     702,844      
Stock options exercised and restricted stock units vested and settled 3,111     3,111    
Capital contribution – stock-based compensation 23     23    
Stock-based compensation 10,197     10,197    
Foreign currency translation adjustments (1,113)       (1,113)  
Net loss (51,418)         (51,418)
Ending balance (in shares) at Dec. 31, 2023   10,000 145,094,052      
Ending balance at Dec. 31, 2023 679,344 $ 0 $ 14 1,430,294 (600) (750,364)
Beginning balance (in shares) at Mar. 31, 2024   10,000 145,582,999      
Beginning balance at Mar. 31, 2024 617,757 $ 0 $ 14 1,441,518 1,908 (825,683)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock options exercised and restricted stock units vested and settled (in shares)     612,674      
Stock options exercised and restricted stock units vested and settled 686     686    
Capital contribution – stock-based compensation 12     12    
Stock-based compensation 13,443     13,443    
Foreign currency translation adjustments (88)       (88)  
Net loss (87,150)         (87,150)
Ending balance (in shares) at Jun. 30, 2024   10,000 146,195,673      
Ending balance at Jun. 30, 2024 544,660 $ 0 $ 14 1,455,659 1,820 (912,833)
Beginning balance (in shares) at Mar. 31, 2024   10,000 145,582,999      
Beginning balance at Mar. 31, 2024 617,757 $ 0 $ 14 1,441,518 1,908 (825,683)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (307,391)          
Ending balance (in shares) at Dec. 31, 2024   10,000 147,203,565      
Ending balance at Dec. 31, 2024 352,617 $ 0 $ 14 1,483,198 2,479 (1,133,074)
Beginning balance (in shares) at Jun. 30, 2024   10,000 146,195,673      
Beginning balance at Jun. 30, 2024 544,660 $ 0 $ 14 1,455,659 1,820 (912,833)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock options exercised and restricted stock units vested and settled (in shares)     369,376      
Stock options exercised and restricted stock units vested and settled 730     730    
Capital contribution – stock-based compensation 8     8    
Stock-based compensation 12,685     12,685    
Foreign currency translation adjustments 90       90  
Net loss (109,119)         (109,119)
Ending balance (in shares) at Sep. 30, 2024   10,000 146,565,049      
Ending balance at Sep. 30, 2024 449,054 $ 0 $ 14 1,469,082 1,910 (1,021,952)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock options exercised and restricted stock units vested and settled (in shares)     638,516      
Stock options exercised and restricted stock units vested and settled 2,464   $ 0 2,464    
Capital contribution – stock-based compensation 3     3    
Stock-based compensation 11,649     11,649    
Foreign currency translation adjustments 569       569  
Net loss (111,122)         (111,122)
Ending balance (in shares) at Dec. 31, 2024   10,000 147,203,565      
Ending balance at Dec. 31, 2024 $ 352,617 $ 0 $ 14 $ 1,483,198 $ 2,479 $ (1,133,074)